The downgrade by a major analyst like UBS from Buy to Neutral, coupled with a significant reduction in the price target, suggests a bearish outlook on APD. This could lead to a negative short-term impact on the stock as investors and market participants reassess the company's future growth prospects and valuation. The confidence in this analysis is high due to the direct impact analyst ratings and price target adjustments typically have on stock prices.